Presidi per laparoscopia
TED · 472960-2026Award noticeNo deadline given
Value
Estimated€453,600 · 453,600 EUR
Awarded—
Who already wins at this buyer
Firms with recorded awards from IRCCS “S. De Bellis” in this tender’s CPV categories — the incumbents you are bidding against.
| Firm | Wins | Awarded | Last win |
|---|---|---|---|
| MEDITALIA GROUP S.R.L. | essepi srl service and partners | OLYMPUS ITALIA | INNOVAMEDICA | M.G. Lorenzatto | EUROMEDICAL | STERIS Italy S.r.l. | NEW MEDICAL SOLUTIONS SRL | LOHMANN & RAUSCHER SRL | ERBE ITALIA S.r.l. | MEDTRONIC ITALIA SPA | Fresenius Kabi Italia | 1 | €3,338,438 | 2026-06-18 |
| MEDTRONIC ITALIA SPA | OLYMPUS ITALIA | Johnson & Johnson Medical S.p.A. | 1 | €846,234 | 2026-06-18 |
| biomerieux italia | Beta Diagnostici | 1 | €435,000 | 2026-07-07 |
| BENEFIS S.R.L. | CAIR ITALIA | CERACARTA | LAWS Medical Equipment srl | 1 | €382,865 | 2026-07-07 |
| BETAFIN | 1 | €300,000 | 2026-07-07 |
Full buyer profile: what IRCCS “S. De Bellis” buys and who wins it →
CPV codes
33190000 Medical equipment & pharmaceuticalsDescription
Gara Europea a procedura aperta telematica per l’affidamento, per 36 mesi, della fornitura, suddivisa in n. 11 lotti, di presidi per laparoscopia occorrenti al Blocco Operatorio dell’Istituto
Similar tenders
Closest by meaning — across languages, via embeddings.
| Published | Title | Buyer | Match |
|---|---|---|---|
| 2026-07-09 | Presidi per laparoscopia | IRCCS “S. De Bellis” IT | 100% |
| 2026-07-07 | Gara dispositivi chirurgia epatica | IRCCS “S. De Bellis” IT | 94% |
| 2026-07-07 | Gara europea Dispositivi Endoscopia | IRCCS “S. De Bellis” IT | 93% |
| 2026-07-07 | GARA EUROPEA SISTEMI DI DIAGNOSTICA DI LABORATORIO IN N.10 LOTTI | IRCCS “S. De Bellis” IT | 93% |
| 2026-06-05 | Gara Europea a procedura aperta telematica, ai sensi degli artt. 25 e 71 del D. Lgs. 36/2023 e s.m.i per l'affidamento della fornitura suddivisa in 6 lotti di dispositivi per accessi vascolari per una | IRCCS “S. De Bellis” IT | 93% |
| 2026-07-07 | Gara deflussori per somministrazione farmaci citotossici | IRCCS “S. De Bellis” IT | 92% |